We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · September 05, 2020

Entospletinib With Induction Chemotherapy in Previously Untreated Acute Myeloid Leukemia

Clinical Cancer Research


Additional Info

Clinical Cancer Research
Entospletinib in Combination With Induction Chemotherapy in Previously Untreated Acute Myeloid Leukemia: Response and Predictive Significance of HOXA9 and MEIS1 Expression
Clin. Cancer Res 2020 Aug 20;[EPub Ahead of Print], A Walker, JC Byrd, JS Blachly, B Bhatnagar, A Mims, S Orwick, TL Lin, HE Crosswell, D Zhang, MD Minden, V Munugalavadla, L Long, J Liu, Y Pan, T Oellerich, H Serve, AV Rao, WG Blum

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading